Issie Kirby
Stock Analyst at Redburn Atlantic
(0)
# 3944
Out of 5,271 analysts
7
Total ratings
25.00%
Success rate
-4.43%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DexCom | Upgrades: Buy | 85 115 | 85.94 | 33.81% | 2 | Feb 3, 2025 | |
Alcon | Upgrades: Neutral | n/a | n/a | n/a | 1 | Oct 10, 2024 | |
Tandem Diabetes Care | Initiates Coverage On: Buy | 60 | 20.75 | 189.16% | 1 | May 30, 2024 | |
Insulet | Initiates Coverage On: Buy | 235 | 272.76 | -13.84% | 1 | May 30, 2024 | |
Cooper Companies | Upgrades: Buy | 125 | 91.64 | 36.4% | 2 | Mar 19, 2024 |